Afynia

Explain the pain

Austin, United States · Founded 2021 · $7.0M raised

Headquarters
Austin, Texas
Founded
2021
Business Model
B2C
Total Funding
$7.0M
Last Round
$5.0M SeedFeb 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.

About

Afynia, formerly known as AIMA Laboratories, is a Canadian diagnostics company developing a blood-based test to help identify endometriosis, a condition that affects roughly 1 in 10 women of reproductive age and often takes 5 to 12 years to diagnose. The company's four-step process — physician consultation, blood draw, laboratory microscopy analysis, and a personalized health plan — aims to give patients and physicians faster clarity on chronic pelvic pain, painful periods, and infertility linked to endometriosis. Afynia's mission is to shorten the diagnostic delay that leaves many women without answers for their symptoms.

Summary

Afynia is a Biotech company based in Austin, United States, founded in 2021. It has raised $7.0M in total across 2 rounds, most recently a $5.0M Seed round in Feb 2025. Investors include Capital Angel Network, Bio-Rad Laboratories and Impact America Fund.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundFeb 2025
$5.0M

Sign up to see all 2 events

Funding: Pre-Seed through Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Afynia on Indexed.vc
<a href="https://indexed.vc/companies/afynia"><img src="https://indexed.vc/api/badge/company/afynia" alt="Afynia on Indexed.vc" width="260" height="76" /></a>